Celyad Oncology SA financial statements
Celyad Oncology SA's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | EUR 21K | EODHD |
| Net income | EUR 830K | EODHD |
| Cash and equivalents | EUR 1.71M | EODHD |
Celyad Oncology SA financials on 6ix · Celyad Oncology SA on 6ix